Huperzine A and Huperzine A for Cognition in dementia
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Huperzine A
A potent acetylcholinesterase inhibitor with some dementia data — effectively a drug, not a casual nootropic.
Grade C1 graded outcomerevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Huperzine A for Cognition in dementia
Evidence grade C — Variable-quality trials
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Huperzine A | Huperzine A for Cognition in dementia |
|---|---|---|
| Cognition in dementia | Evidence grade CSmall effectmixedVariable-quality trials | Evidence grade CSmall effectmixedVariable-quality trials |
Graded only in Huperzine A
None — every outcome it grades is graded in both.
Graded only in Huperzine A for Cognition in dementia
None — every outcome it grades is graded in both.
Conditions
Only in Huperzine A
- Dementia May improveEvidence grade C
Only in Huperzine A for Cognition in dementia
None.
What each entry says about the other
- Huperzine A for Cognition in dementia’s entry · Goes with: Read the full Huperzine A monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.